The mission of the OGO Latin America Office (LAO) is to help assure the safety and quality of food, feed, drugs and medical devices produced in Latin America. The OGO/LAO operates three posts: San Jose, Costa Rica (headquarters), Mexico City, Mexico and Santiago, Chile, which have purview over 44 countries and territories in the FDA’s Latin American region including Mexico, Central America, South America and the Caribbean. OGPS is currently considering integrating Canada into the office and renaming it the Americas Office. The mission of the OGO/LAO is to implement FDA’s regulations and policies in the region. Specifically, LAO works both independently and alongside the Centers to assess the capacity of governments to manage, assess, and regulate products within increasingly complex scenarios affecting product safety and efficacy.
Focus on Latin America
- Safety of Drug Residues in Animals Destined for Human Consumption
- FDA Team Expert in Norovirus Supports the ISP with Methodologies for the Detection of the Virus
- FDA Expands Presence Outside U.S. with Opening of Mexico City Post
- HHS-FDA Launches first-event Workshop on Good Clinical Practices in the Americas